Comparative analysis of the cardioprotective properties of opioid receptor agonists in a rat model of myocardial infarction

Academic Emergency Medicine

Volumn 17, Issue 11, 2010, Pages 1239-1246

  Maslov, Leonid N ^a   Lishmanov, Yury B ^a   Oeltgen, Peter R ^b   Barzakh, Eva I ^d   Krylatov, Andrey V ^a   Naryzhnaya, Natalia V ^a,e   Pei, Jian Ming ^f   Brown, Stephen A ^b,c  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e TOMSK STATE PEDAGOGICAL UNIVERSITY   (Russian Federation)

^f FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

heart; ischemia; opioid receptors; reperfusion

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN D; DELTORPHIN E; DELTORPHIN II; DERMORPHIN H; DIMETHYL SULFOXIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MU OPIATE RECEPTOR AGONIST; NOCICEPTIN; OPIATE AGONIST; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRADYCARDIA; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY REPERFUSION; DOSE RESPONSE; DRUG EFFECT; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; HEART RATE; IN VIVO STUDY; LEFT CORONARY ARTERY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; BETA-CYCLODEXTRINS; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; EXCIPIENTS; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OLIGOPEPTIDES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, OPIOID;

EID: 78349232806     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2010.00910.x     Document Type: Article

References (39)

1. Schultz JE, Hsu AK, Gross GJ,. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 1997; 29: 2187-95.
2. Coles JA, Sigg DC, Iaizzo PA,. The role of κ-opioid receptor activation in pharmacological preconditioning of swine. Am J Physiol Heart Circ Physiol. 2003; 284: H2091-9.
3. ATP channels. Am J Physiol. 1998; 274: H909-14.
4. Fryer RM, Wang Y, Hsu AK, Gross GJ,. Essential activation of PKC-δ in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol. 2001; 280: H1346-53.
5. Sigg DC, Coles JA, Oeltgen PR, Iaizzo PA,. Role of δ-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol. 2002; 282: H1953-60.
6. 1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res. 2004; 61: 591-9.
7. 1- but not μ- or κ-opioid receptors. Circulation. 1998; 97: 1282-9.
8. Wang GY, Wu S, Pei JM, Yu XC, Wong TM,. κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmias in rats. Am J Physiol Heart Circ Physiol. 2001; 280: H384-91.
9. Peart JN, Gross ER, Gross GJ,. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction. J Cardiovasc Pharmacol. 2004; 43: 410-5.
10. Cheng L, Ma S, Wei LX, et al., Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart. Heart Vessels. 2007; 22: 335-44.
11. ATP channels. Am J Physiol Heart Circ Physiol. 2003; 285: H1032-9.
12. Wu S, Li HY, Wong TM,. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of κ-opioid receptor. Circ Res. 1999; 84: 1388-95.
13. Ho JC, Wu S, Kam KW, Sham JS, Wong TM,. Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia. Br J Pharmacol. 2002; 137: 739-48.
14. Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM, Opie LH,. Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol. 2000; 95: 1-10.
15. Maslov LN, Lishmanov YuB,. Role of central and peripheral mu-and delta-opiate receptors in mechanisms of the antiarrhythmic action of enkephalins. Bull Exp Biol Med. 1991; 112: 1066-8.
16. Maslov LN, Lishmanov Yu B,. The anti-arrhythmic effect of D-Ala2,Leu5,Arg6-enkephalin and its possible mechanism. Int J Cardiol. 1993; 40: 89-94.
17. + channels of cardiomyocytes. Bull Exp Biol Med. 1998; 126: 1224-6.
18. + channels. Life Sci. 2003; 73: 947-52.
19. 2+ in the rat heart as revealed by κ-opioid receptor stimulation with U50488H. Br J Pharmacol. 2003; 140: 750-8.
20. Emmerson PJ, Liu MR, Woods JH, Medzihradsky F,. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther. 1994; 271: 1630-7.
21. Varga EV, Li X, Stropova D, et al., The third extracellular loop of the human δ-opioid receptor determines the selectivity of δ-opioid agonists. Mol Pharmacol. 1996; 50: 1619-24.
22. Delay-Goyet P, Ruiz-Gayo M, Baamonde A, Gacei G, Morgat JL, Roques BP,. Brain passage of BUBU, a highly selective and potent agonist for δ opioid receptors: in vivo binding and μ versus δ receptor occupancy. Pharmacol Biochem Behav. 1990; 38: 155-62.
23. 2]deltorphin II in mice: evidence for delta receptor subtypes. J Pharmacol Exp Ther. 1991; 258: 583-7.
24. 3H]U-69593 a highly selective ligand for the opioid κ receptor. Eur J Pharmacol. 1985; 109: 281-4.
25. Birch PJ, Rogers H, Hayes AG, et al., Neuroprotective actions of GR89696, a highly potent and selective κ-opioid receptor agonist. Br J Pharmacol. 1991; 103: 1819-23.
26. Butelman ER, Ko MC, Traynor JR, Vivian JA, Kreek MJ, Woods JH,. GR 89,696: a potent kappa-opioid agonist with subtype selectivity in rhesus monkeys. J Pharmacol Exp Ther. 2001; 298: 1049-59.
27. Meunier JC, Mollereau C, Toll L, et al., Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995; 377: 532-5.
28. ATP channels and the autonomic nervous system. Life Sci. 2009; 84: 657-63.
29. Polonskii VM, Yarygin KN, Krovosheev OG, Moskovkin GN, Vinogradov VA,. Effect of the antiulcerative action (central or peripheral) of the synthetic enkaphalin analog dalargin in experimental cysteamine-induced duodenal ulcer in rats. Bull Exp Biol Med. 1987; 103: 488-90.
30. Samii A, Bickel U, Stroth U, Pardridge WM,. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol. 1994; 267: E124-31.
31. Groban L, Vernon JC, Butterworth J,. Intrathecal morphine reduces infarct size in a rat model of ischemia-reperfusion injury. Anesth Analg. 2004; 98: 903-9.
32. Li R, Wong GT, Wong TM, Zhang Y, Xia Z, Irwin mg,. Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats. Anesth Analg. 2009; 108: 23-9.
33. Lishmanov YuB, Maslov LN, Lasukova TV, Platonov AA, Oeltgen PR,. Activation of δ-opioid receptors increases resistance of isolated heart to ischemia/reperfusion: the role of cAMP and intracellular calcium. Biol Bull. 2005; 32: 45-51.
34. Platonov AA, Lasukova TV, Maslov LN, Downey JM, Nagaze H, Ovinnikov MV,. [Delta -opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemic perfused rat heart] (Russian). Exp Clin Pharmacol. 2004; 67: 26-9.
35. Miura T, Goto M, Miki T, Sakamoto J, Shimamoto K, Iimura O,. Glibenclamide, a blocker of ATP-sensitive potassium channels, abolishes infarct size limitation by preconditioning in rabbits anesthetized with xylazine/pentobarbital but not with pentobarbital alone. J Cardiovasc Pharmacol. 1995; 25: 531-8.
36. Sander GE, Lowe RF, Giles TD,. The effects of barbiturates upon the hemodynamic responses to intravenous methionine-enkephalin in dogs: modulation by the GABA complex. Peptides. 1986; 7: 259-65.
37. Haessler R, Kuzume K, Chien GL, Wolff RA, Davis RF, Van Winkle DM,. Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res. 1994; 28: 1574-80.
38. 1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med. 2007; 143: 22-5.
39. 2 opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in rats. Shock. 2008; 29: 42-8.